-+ 0.00%
-+ 0.00%
-+ 0.00%

Amwell Q3 adjusted EBITDA loss narrows 72% year over year to $3.6 million

PUBT·11/03/2026 21:17:04
Listen to the news
Amwell Q3 adjusted EBITDA loss narrows 72% year over year to $3.6 million
  • Amwell’s Q3 2026 adjusted EBITDA loss narrowed 72% year-over-year to $3.6 million.
  • The company raised its 2026 adjusted EBITDA outlook to a loss of $7 million to $8 million.
  • Q4 2026 adjusted EBITDA is expected to range from breakeven to $1 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. American Well Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611031605PRIMZONEFULLFEED9868881) on November 03, 2026, and is solely responsible for the information contained therein.